These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 28745721)

  • 1. Gas Plasma Exposure of Glioblastoma Is Cytotoxic and Immunomodulatory in Patient-Derived GBM Tissue.
    Bekeschus S; Ispirjan M; Freund E; Kinnen F; Moritz J; Saadati F; Eckroth J; Singer D; Stope MB; Wende K; Ritter CA; Schroeder HWS; Marx S
    Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CR13626: a novel oral brain penetrant tyrosine kinase inhibitor that reduces tumor growth and prolongs survival in a mouse model of glioblastoma.
    Galimberti C; Piepoli T; Letari O; Artusi R; Persiani S; Caselli G; Rovati LC
    Am J Cancer Res; 2021; 11(7):3558-3574. PubMed ID: 34354860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor in lung cancer: Complex roles in biology and resistance to treatment.
    Gong K; Guo G; Beckley N; Zhang Y; Yang X; Sharma M; Habib AA
    Neoplasia; 2021 Feb; 23(2):189-196. PubMed ID: 33373873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR inhibition triggers an adaptive response by co-opting antiviral signaling pathways in lung cancer.
    Gong K; Guo G; Panchani N; Bender ME; Gerber DE; Minna JD; Fattah F; Gao B; Peyton M; Kernstine K; Mukherjee B; Burma S; Chiang CM; Zhang S; Amod Sathe A; Xing C; Dao KH; Zhao D; Akbay EA; Habib AA
    Nat Cancer; 2020 Apr; 1(4):394-409. PubMed ID: 33269343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of EGFR plus TNF inhibition in a preclinical model of temozolomide-resistant glioblastoma.
    Guo G; Gong K; Puliyappadamba VT; Panchani N; Pan E; Mukherjee B; Damanwalla Z; Bharia S; Hatanpaa KJ; Gerber DE; Mickey BE; Patel TR; Sarkaria JN; Zhao D; Burma S; Habib AA
    Neuro Oncol; 2019 Dec; 21(12):1529-1539. PubMed ID: 31363754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNF-driven adaptive response mediates resistance to EGFR inhibition in lung cancer.
    Gong K; Guo G; Gerber DE; Gao B; Peyton M; Huang C; Minna JD; Hatanpaa KJ; Kernstine K; Cai L; Xie Y; Zhu H; Fattah FJ; Zhang S; Takahashi M; Mukherjee B; Burma S; Dowell J; Dao K; Papadimitrakopoulou VA; Olivas V; Bivona TG; Zhao D; Habib AA
    J Clin Invest; 2018 Jun; 128(6):2500-2518. PubMed ID: 29613856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting epidermal growth factor receptor co-dependent signaling pathways in glioblastoma.
    Liu F; Mischel PS
    Wiley Interdiscip Rev Syst Biol Med; 2018 Jan; 10(1):. PubMed ID: 28892308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma.
    Li X; Wu C; Chen N; Gu H; Yen A; Cao L; Wang E; Wang L
    Oncotarget; 2016 May; 7(22):33440-50. PubMed ID: 26967052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helping EGFR inhibition to block cancer.
    Warta R; Herold-Mende C
    Nat Neurosci; 2017 Jul; 20(8):1035-1037. PubMed ID: 28745721
    [No Abstract]   [Full Text] [Related]  

  • 10. Cross-talk between sphingosine-1-phosphate and EGFR signaling pathways enhances human glioblastoma cell invasiveness.
    Cattaneo MG; Vanetti C; Samarani M; Aureli M; Bassi R; Sonnino S; Giussani P
    FEBS Lett; 2018 Mar; 592(6):949-961. PubMed ID: 29427528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A TNF-JNK-Axl-ERK signaling axis mediates primary resistance to EGFR inhibition in glioblastoma.
    Guo G; Gong K; Ali S; Ali N; Shallwani S; Hatanpaa KJ; Pan E; Mickey B; Burma S; Wang DH; Kesari S; Sarkaria JN; Zhao D; Habib AA
    Nat Neurosci; 2017 Aug; 20(8):1074-1084. PubMed ID: 28604685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trans receptor inhibition of human glioblastoma cells by erbB family ectodomains.
    O'Rourke DM; Qian X; Zhang HT; Davis JG; Nute E; Meinkoth J; Greene MI
    Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3250-5. PubMed ID: 9096379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic EGFR Represses the TET1 DNA Demethylase to Induce Silencing of Tumor Suppressors in Cancer Cells.
    Forloni M; Gupta R; Nagarajan A; Sun LS; Dong Y; Pirazzoli V; Toki M; Wurtz A; Melnick MA; Kobayashi S; Homer RJ; Rimm DL; Gettinger SJ; Politi K; Dogra SK; Wajapeyee N
    Cell Rep; 2016 Jul; 16(2):457-471. PubMed ID: 27346347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained mitogen-activated protein kinase activation is induced by transforming erbB receptor complexes.
    Wu CJ; Qian X; O'Rourke DM
    DNA Cell Biol; 1999 Oct; 18(10):731-41. PubMed ID: 10541432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation.
    Eskilsson E; Rosland GV; Talasila KM; Knappskog S; Keunen O; Sottoriva A; Foerster S; Solecki G; Taxt T; Jirik R; Fritah S; Harter PN; Välk K; Al Hossain J; Joseph JV; Jahedi R; Saed HS; Piccirillo SG; Spiteri I; Leiss L; Euskirchen P; Graziani G; Daubon T; Lund-Johansen M; Enger PØ; Winkler F; Ritter CA; Niclou SP; Watts C; Bjerkvig R; Miletic H
    Neuro Oncol; 2016 Dec; 18(12):1644-1655. PubMed ID: 27286795
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.